INCR Earnings
InterCure Ltd
$
1.520
- Overview
- Forecast
- Valuation
- Earnings
Earning Analysis
Welcome to our in-depth analysis of InterCure Ltd(INCR) earnings, offering investors a detailed look into the company’s financial performance, revenue trends, earnings per share (EPS), and market reactions. This page provides a comprehensive overview of InterCure Ltd earnings history, forecasts, and key financial metrics, empowering you with the data needed to make informed investment decisions. Whether you're tracking quarterly results, analyzing earnings surprises, or exploring future projections, our detailed breakdown covers it all.
Earnings Forecast
Revenue
EPS
Currency: ILS
Actual
Estimate
Surprise Analysis
| - | 2024-07-01 | - | - | 0.00 | - | - | - | - | +1.00 | +15.42 |
INCR Earnings Analysis
Our earnings analysis provides a granular look at the company’s performance across recent fiscal quarters, highlighting key metrics such as revenue, EPS, and operating margins. By examining actual results against analyst estimates, we uncover trends and surprises that drive stock price movements, offering valuable insights for both short-term traders and long-term investors.
In the most recent quarter, InterCure Ltd reported performance for , announced on 2024-07-01. The company achieved an EPS of 0.00, compared to analyst estimates of by % . Revenue for the quarter reached 0.00 compared to expectations of 0.00 by % .
The stock price reacted with a 1.00% one-day change and a 15.42% five-day change following the earnings release. These movements reflect market reaction in InterCure Ltd growth trajectory and strategic initiatives.
INCR Earnings Forecast
Looking ahead, InterCure Ltd(INCR) remains a focal point for investors seeking growth opportunities. Analyst forecasts for project quarter revenue of and an EPS of .
However, recent estimate revisions provide additional context. Over the past three months, revenue estimates for have been Go Up by 12.59%, while EPS estimates have been No Change by %. For the upcoming , revenue estimates have been adjusted No Change by % . These revisions correlate with a % change in stock price over the same period, suggesting potential buying opportunities for investors who believe in InterCure Ltd long-term fundamentals.
The relationship between earnings forecast revisions and stock price movements is critical for investors. Positive revisions in revenue or EPS often signal strengthening fundamentals, making temporary price dips attractive entry points. Conversely, downward revisions may reflect short-term challenges.
Estimate Revision
The chart shows the correlation between INCR's stock price and earnings forecast revisions. Positive revisions in Revenue or EPS often strengthen the stock's fundamentals, making price dips potential buying opportunities.
Stock Price
Go Up
+12.59%
In Past 3 Month
1Y
3Y
5Y
Fiscal Period
Currency: USD
1Y
3Y
5Y
--
Revenue Estimate-:0
--
EPS Estimate-:0
—
Stock Price1.52
INCR Revenue and EPS Performance: A Historical Perspective
InterCure Ltd revenue and earnings per share (EPS) performance over recent quarters provides a clear picture of its financial health. Below is a detailed breakdown of the company’s earnings history, showcasing actual results, analyst estimates, and surprise percentages for key fiscal quarters:
(2024-07-01,):
EPS: 0.00 (Actual) vs. (Estimate) (%)
Revenue: 0.00 (Actual) vs. 0.00 (Estimate) (%)
Price Reaction: 1.00%(1-Day), 15.42%(5-Day)
(,):
EPS: (Actual) vs. (Estimate) (%)
Revenue: (Actual) vs. (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
(,):
EPS: (Actual) vs. (Estimate) (%)
Revenue: (Actual) vs. (Estimate) (%)
Price Reaction: %(1-Day), %(5-Day)
Earnings Reaction
The chart below shows how INCR performed 10 days before and after its earnings report, based on data from the past quarters. Typically, INCR sees a +16.26% change in stock price 10 days leading up to the earnings, and a +19.21% change 10 days following the report. On the earnings day itself, the stock moves by +1.00%. This data can give you a slight idea of what to expect for the next quarter's release.
For example, in MAR/2024, the stock changed 0.99% on the day following the earnings release and then changed by 19.21% over the next 10 days. These patterns provide investors with valuable insights into potential price movements and help inform trading strategies around earnings events.
Transcript Summary
No Data
People Also Watch
LSBK
Lake Shore Bancorp Inc
15.790
USD
-0.88%
CATO
Cato Corp
2.820
USD
+0.36%
GALT
Galectin Therapeutics Inc
2.800
USD
-3.11%
ANIX
Anixa Biosciences Inc
3.440
USD
+2.69%
PBHC
Pathfinder Bancorp Inc (MARYLAND)
15.250
USD
+0.07%
WLGS
WANG & LEE GROUP Inc
0.047
USD
+12.05%
EPIX
ESSA Pharma Inc
1.880
USD
+0.53%
IPSC
Century Therapeutics Inc
0.581
USD
+0.17%
OKUR
Onkure Therapeutics Inc
2.330
USD
-2.10%
CTM
Castellum Inc
1.490
USD
+6.43%
FAQ
What were the key highlights of INCR’s latest earnings report for ?
INCR reported its earnings on 2024-07-01, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a 1% price change on the earnings day and a 15.42% change over the next five days, reflecting market reactions to the results.
How did INCR’s stock price react after the earnings release?
What are the revenue and EPS estimates for INCR for undefined?
How does INCR’s stock price correlate with earnings forecast revisions?
What should investors expect from INCR’s next earnings report?